BioAtla (BCAB) Payables (2020 - 2026)

BioAtla's Payables history runs 7 years deep, the most recent figure standing at $19.1 million for Q1 2026.

• On a quarterly basis, Payables rose 23.82% year-over-year to $19.1 million in Q1 2026; TTM through Mar 2026 was $19.1 million, a 23.82% increase from a year earlier, with the FY2025 full-year figure at $16.4 million, up 759.78% from the prior year.
• Payables grew to $19.1 million in Q1 2026 per BCAB's latest filing, from $16.4 million in the prior quarter.
• Across five years, Payables topped out at $32.1 million in Q2 2023 and bottomed at $1.2 million in Q1 2022.
• The 5-year median for Payables is $15.8 million (2024), against an average of $14.0 million.
• Across the five-year window, Payables sank 88.39% in 2022 and jumped 1960.97% in 2023, its largest moves.
• Year by year, Payables stood at $4.2 million in 2022, then dropped by 9.74% to $3.8 million in 2023, then tumbled by 50.2% to $1.9 million in 2024, then surged by 759.78% to $16.4 million in 2025, then increased by 17.0% to $19.1 million in 2026.
• Per Business Quant, the three latest BCAB Payables figures stand at $19.1 million (Q1 2026), $16.4 million (Q4 2025), and $16.8 million (Q3 2025).